Astellas Announces Acquisition of Own Shares and Cancellation of Treasury Stock

On February 6, 2023 Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") reported that at the meeting of the Board of Directors held today, a resolution was adopted to acquire its own shares pursuant to the provision of its Articles of Incorporation in accordance with Article 459, paragraph 1 of the Companies Act (Press release, Astellas, FEB 6, 2023, View Source [SID1234626858]). The Company also announced that it decided to cancel its treasury stock pursuant to the provisions of Article 178 of the Companies Act. The details are as follows.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Reasons for the acquisition of own shares
To improve capital efficiency and shareholder return.

Details of the acquisition of own shares
(1) Class of shares to be acquired:　　Common stock of the Company
(2) Total number of shares to be acquired:　　Up to 29 million shares
　　　　　　(Ratio to the total number of shares outstanding [excluding treasury stock]: 1.59%)
(3) Total amount of acquisition cost:　　Up to 50 billion yen
(4) Period of acquisition:　　From February 7, 2023 to March 24 ,2023
(5) Method of acquisition:　　Marked purchase on the Tokyo Stock Exchange

Details of the cancellation of treasury stock
(1) Class of shares to be cancelled:　　Common stock of the Company
(2) Number of shares to be cancelled:　　All of the shares acquired as stated in 2 above
(3) Cancellation date:　　March 29, 2023 (planned)
＊ The actual number of shares to be cancelled will be announced after
completing the acquisition of own shares stated in 2 above.
(Reference) Status of treasury stock as of December 31, 2022:

Total number of shares outstanding (excluding treasury stock): 1,822,806,495 shares
Total number of treasury stocks: 13,045,080 shares